Buczyńska, A.; Sidorkiewicz, I.; Ławicki, S.; Krętowski, A.; Zbucka-Krętowska, M.
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome. J. Clin. Med. 2020, 9, 3995.
https://doi.org/10.3390/jcm9123995
AMA Style
Buczyńska A, Sidorkiewicz I, Ławicki S, Krętowski A, Zbucka-Krętowska M.
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome. Journal of Clinical Medicine. 2020; 9(12):3995.
https://doi.org/10.3390/jcm9123995
Chicago/Turabian Style
Buczyńska, Angelika, Iwona Sidorkiewicz, Sławomir Ławicki, Adam Krętowski, and Monika Zbucka-Krętowska.
2020. "The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome" Journal of Clinical Medicine 9, no. 12: 3995.
https://doi.org/10.3390/jcm9123995
APA Style
Buczyńska, A., Sidorkiewicz, I., Ławicki, S., Krętowski, A., & Zbucka-Krętowska, M.
(2020). The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome. Journal of Clinical Medicine, 9(12), 3995.
https://doi.org/10.3390/jcm9123995